Donald Light, professor of comparative health policy at the University of Medicine and Dentistry of New Jersey, says the pharmaceutical industry is a market for 'lemons' -  a market in which the seller knows much more than the buyer about the product and can profit from selling products less effective and even less safe than consumers are led to believe.

Talking at the meeting of the American Sociological Association, he said three reasons why the pharmaceutical market produces "lemons" are: Having companies in charge of testing new drugs, providing firewalls of legal protection behind which information about harms or effectiveness can be hidden, and the relatively low bar set for drug efficacy in order for a new drug to be approved.

A new Rice University study's side-by-side comparison of 10 human genetic models to determine when 'mitochondrial Eve'(mtEve), the maternal ancestor of all living humans, lived uses a very different set of assumptions about the way humans migrated, expanded and spread across Earth - and it won't be without some controversy.

Mitochondrial Eve studies are an example of how scientists probe the genetic past to learn more about mutation, selection and other genetic processes that play key roles in disease but deterministic models may not be enough, says the new study.     Statisticians to the rescue.

The Open Source movement has been an integral part of software development for many years now, and it is starting to explode into the science world. The latest project might even transform brain science communication and understanding to a new level as the new Whole Brain Catalog is now available for anyone to access.